Blueprint Medicines
BPMC
#2359
Rank
NZ$11.01 B
Marketcap
$172.37
Share price
6.80%
Change (1 day)
10.65%
Change (1 year)

EPS for Blueprint Medicines (BPMC)

EPS in 2023 (TTM): -$14.88

According to Blueprint Medicines 's latest financial reports the company's current EPS (TTM) is -$16.40. In 2022 the company made an earnings per share (EPS) of -$16.69 an increase over its 2021 EPS that were of -$19.60.

EPS history for Blueprint Medicines from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$14.88-10.82%
2022-$16.69-14.85%
2021-$19.60-297.13%
2020$9.94-176.3%
2019-$13.0335.19%
2018-$9.6438.82%
2017-$6.9447.35%
2016-$4.719.25%
2015-$4.31-31.35%
2014-$6.28

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$0.12-99.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.48-97.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.27-86.18%๐Ÿ‡บ๐Ÿ‡ธ USA